Bli medlem
Bli medlem

Du är här


Getinge Group: Getinge announces date of 2014 Q1 report and conference call

Press Release Getinge 2014-04-02

Getinge will issue its Q1 report for 2014 on Wednesday April 16th 2014
at 13:00 CET, followed by a conference call at 15:00 CET, hosted by
Johan Malmquist, CEO, and Ulf Grunander, CFO.

We invite fund managers, analysts and the media to participate in the
conference call. Please see below details to join the conference:

Swedish dial in number: +46 (0) 8 5033 6538
UK dial in number: +44 (0) 20 3427 1906
US dial in number: +1 212 444 0481
Participant passcode: 5386501
14:45 Call in to the conference
15:00 Review of the Q1 report
15:20 Q&A
16:00 End of conference

Two hours after the end of the conference call, a recorded version of
the conference can be accessed for 5 working days on the following

Sweden: +46 (0) 8 5051 3897
UK: +44 (0) 20 3427 0598
US: +1 347 366 9565
Code: 5386501
During the telephone conference a presentation will be held. To access
the presentation, please use this link:

Alternatively enter the Live Meeting site and log into your meeting
using the Meeting ID and Password below:

Live Meeting:
Your Name: (Enter your name)
Web Meeting ID: 5386501
Web Meeting Password: pw2878
For more information, please contact:
Kornelia Rasmussen
Group Communications
Phone: +46 (0)10 335 5810

GETINGE GROUP is a leading global provider of products and systems
that contribute to quality enhancement and cost efficiency within
healthcare and life sciences. We operate under the three brands of
ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient
mobility and wound management solutions. GETINGE provides solutions
for infection control within healthcare and contamination prevention
within life sciences. MAQUET specializes in solutions, therapies and
products for surgical interventions, interventional cardiology and
intensive care.

The information is such that Getinge AB must disclose in accordance
with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act.


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.